Keywords: Clinical progression modeling, Adaptive Trials, Bayesian
In this talk I will present the use of clinical progression modeling in rare diseases and the statistical and clinical value of these models in clinical trials. The clinical progression models can be combined with innovative trial designs, including adaptive and platform trials to create additional statistical synergy. Several examples will be presented.